Lymphomatoid Papulosis Following Spesolimab Treatment for Generalised Pustular Psoriasis
Fuente:
Wiley Open Access
Saved in:
| Main Authors: | Mizuho Namba, Mika Matsumoto, Naoya Saito, Atsuko Kimura, Chihiro Sagara, Daiki Rokunohe, Eijiro Akasaka |
|---|---|
| Format: | Artículo Open Access |
| Published: |
Wiley
2025
|
| Subjects: | |
| Online Access: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Amoxicillin‐Triggered Flare of Generalized Pustular Psoriasis in a Patient With Homozygous IL36RN Pathogenic Variant Treated With Spesolimab and Cyclosporin A
by: Koki Morita, et al.
Published: (2025)
by: Koki Morita, et al.
Published: (2025)
Radiation Recall Mucositis After Administration of Tegafur‐Gimeracil‐Oteracil Potassium ( TS ‐1)
by: Naoya Saito, et al.
Published: (2026)
by: Naoya Saito, et al.
Published: (2026)
Spontaneous Resolution of Cutaneous Siderosis Caused by Extravasation of Intravenous Ferric Derisomaltose: Two Case Reports
by: Chihiro Sagara, et al.
Published: (2026)
by: Chihiro Sagara, et al.
Published: (2026)
The Efficacy and Safety of Non‐Biologic and Biologic Treatments in Palmoplantar Pustular Psoriasis and Palmoplantar Pustulosis: A Systematic Review and Network Meta‐Analysis
by: Khalid M. Alshareef, et al.
Published: (2025)
by: Khalid M. Alshareef, et al.
Published: (2025)
Paediatric Psoriasis and the Topical Treatment Guidance Gap in Australia
by: James Gaston, et al.
Published: (2026)
by: James Gaston, et al.
Published: (2026)
Successful Treatment of Spontaneous Generalised Keloids With Dupilumab: A Case Report
by: Lachlan D. W. Lau, et al.
Published: (2025)
by: Lachlan D. W. Lau, et al.
Published: (2025)
‘Psoriasis Punctata’: An Under‐Recognised Clinical Phenotype of TNF‐Alpha Inhibitor‐Induced Psoriasis
by: Grace Im, et al.
Published: (2025)
by: Grace Im, et al.
Published: (2025)
The Use of Etanercept in the Palliative Treatment of a Patient With Generalised Bullous Fixed Drug Eruption
by: Olga Pawlik, et al.
Published: (2025)
by: Olga Pawlik, et al.
Published: (2025)
Improving Cardiovascular Outcomes in the Psoriasis Cohort. Psoriasis and Cardiovascular Disease–Patient Knowledge, Perspectives and Practice
by: Annika Smith, et al.
Published: (2025)
by: Annika Smith, et al.
Published: (2025)
Improving Cardiovascular Outcomes in the Psoriasis Cohort. Psoriasis and Cardiovascular Disease—Clinician Knowledge, Practice and Perceptions
by: Annika Smith, et al.
Published: (2025)
by: Annika Smith, et al.
Published: (2025)
Health Equity and Secukinumab for Severe Psoriasis in New Zealand
by: Anna Luo, et al.
Published: (2025)
by: Anna Luo, et al.
Published: (2025)
Drug Survival of Biological Therapies in Smokers and Non‐Smokers With Psoriasis: A Retrospective Cohort Study Using Data From the Australasian Psoriasis Registry
by: Ferial May, et al.
Published: (2025)
by: Ferial May, et al.
Published: (2025)
Retrospective Review on Safety and Efficacy of Combination Biologic Therapy for Psoriasis
by: Nicole Kah Mun Yoong, et al.
Published: (2025)
by: Nicole Kah Mun Yoong, et al.
Published: (2025)
Misleading Hepatitis B Serology Following Intravenous Immunoglobulin Treatment for Pemphigus Vulgaris
by: Jessica Gartside, et al.
Published: (2025)
by: Jessica Gartside, et al.
Published: (2025)
Time to Recognise Psoriasis as a Cardiovascular Risk Modifier in National Guidance
by: Annika Smith, et al.
Published: (2025)
by: Annika Smith, et al.
Published: (2025)
Adult Vulval Psoriasis: Clinical Presentation, Management and Impact on Quality of Life
by: Michelle Wu, et al.
Published: (2025)
by: Michelle Wu, et al.
Published: (2025)
A Reply to: ‘Drug Survival of Biologics in Psoriasis: An Australian Multicentre Retrospective Study’
by: Miranda Wallace, et al.
Published: (2025)
by: Miranda Wallace, et al.
Published: (2025)
Efficacy and Safety of Switching From Intravenous to Subcutaneous Infliximab for Psoriasis: A Case Series
by: Conor Larney, et al.
Published: (2024)
by: Conor Larney, et al.
Published: (2024)
Normolipemic xanthoma associated with folliculotropic mycosis fungoides
by: Shunsuke Takahagi, et al.
Published: (2024)
by: Shunsuke Takahagi, et al.
Published: (2024)
Exploring the Impact of Guselkumab and Risankizumab on Psoriasis in HIV‐Positive Patients: Insights From Four Italian Centers
by: V. Maione, et al.
Published: (2025)
by: V. Maione, et al.
Published: (2025)
Successful Treatment of a Case of Scleromyxedema With Intravenous Immunoglobulin and Thalidomide and a Two‐and‐a‐Half‐Year Follow‐Up
by: Deepak Kumar Sahu, et al.
Published: (2025)
by: Deepak Kumar Sahu, et al.
Published: (2025)
Management Strategies for Generalised Granuloma Annulare: A Systematic Review of Current and Emerging Therapies
by: Luca Bettolini, et al.
Published: (2025)
by: Luca Bettolini, et al.
Published: (2025)
The Incidence and Management of TNF‐α Inhibitor Induced Paradoxical Psoriasis in Children With Inflammatory Bowel Disease: A Systematic Review and Meta‐Analysis
by: James Gaston, et al.
Published: (2025)
by: James Gaston, et al.
Published: (2025)
Resolution of Severe Hidradenitis Suppurativa Following Kidney Transplantation
by: Kerem Balan, et al.
Published: (2025)
by: Kerem Balan, et al.
Published: (2025)
Upadacinib for the Treatment of Refractory Morphea
by: Vincenzo Maione, et al.
Published: (2025)
by: Vincenzo Maione, et al.
Published: (2025)
Dupilumab in the Treatment of Cutaneous Lymphoid Hyperplasia
by: Georgia De'Ambrosis, et al.
Published: (2026)
by: Georgia De'Ambrosis, et al.
Published: (2026)
Diagnosis of Mycobacterium marinum Infection Following Seroconversion of QuantiFERON ‐ TB Gold Assay
by: Lily Rath, et al.
Published: (2025)
by: Lily Rath, et al.
Published: (2025)
Treatment of lichen planopilaris with Janus kinase inhibitors
by: Gabriela A. Gonzalez Matheus, et al.
Published: (2024)
by: Gabriela A. Gonzalez Matheus, et al.
Published: (2024)
Successful Treatment of Pyoderma Gangrenosum Associated With Hidradenitis Suppurativa With Bimekizumab
by: Martha A. Oberg, et al.
Published: (2026)
by: Martha A. Oberg, et al.
Published: (2026)
New‐Onset Vitiligo and Change in Disease Status Following COVID ‐19 Vaccination and COVID ‐19 Infection—An Online Survey
by: Raaisa Islam, et al.
Published: (2025)
by: Raaisa Islam, et al.
Published: (2025)
Management of Treatment Resistant EGFR Inhibitor‐Induced Papulopustular Exanthema With Isotretinoin and Dapsone
by: Ishana Dixit, et al.
Published: (2026)
by: Ishana Dixit, et al.
Published: (2026)
Comment on: Rituximab for the Management of an Australian Cohort of Treatment Refractory Mucous Membrane Pemphigoid
by: Chenghong Xu, et al.
Published: (2025)
by: Chenghong Xu, et al.
Published: (2025)
Systematic Review of Rare Major Adverse Cardiovascular Events Associated With the Treatment of Acne With Isotretinoin
by: Timothy L. Cowan, et al.
Published: (2025)
by: Timothy L. Cowan, et al.
Published: (2025)
Systematic Review and Meta‐Analysis of the Efficacy and Risk of Adverse Events of Dupilumab in the Treatment of Prurigo Nodularis
by: Hicham Titou, et al.
Published: (2025)
by: Hicham Titou, et al.
Published: (2025)
Emerging Terbinafine Resistant Trichophyton Dermatophytosis, Testing Options and Alternative Treatments: A Systematic Review
by: Thuvarahan Jegathees, et al.
Published: (2025)
by: Thuvarahan Jegathees, et al.
Published: (2025)
Systemic Treatment of Moderate to Severe Alopecia Areata in Adults: Updated Australian Expert Consensus Statement
by: Daniella Kushnir‐Grinbaum, et al.
Published: (2025)
by: Daniella Kushnir‐Grinbaum, et al.
Published: (2025)
Successful Photodynamic Treatment of a Pigmented Nodular BCC Using a Biphasic Activation Protocol
by: Robert Stephens, et al.
Published: (2025)
by: Robert Stephens, et al.
Published: (2025)
Safety and Immunogenicity of Live Attenuated Vaccine Administration in Patients Undergoing Treatment With Dupilumab and Apremilast: A Systematic Review
by: Conor Larney, et al.
Published: (2025)
by: Conor Larney, et al.
Published: (2025)
Spironolactone for the Treatment of Moderate to Severe Acne in Adult Women: A Systematic Review and Meta‐Analysis of Randomised Controlled Trials
by: Chia Siang Kow, et al.
Published: (2025)
by: Chia Siang Kow, et al.
Published: (2025)
Primary Cutaneous ALK ‐Negative Anaplastic Large Cell Lymphoma in a Filipino Male: Successful Treatment With Gemcitabine and Radiotherapy
by: Krystel Angela A. Olano, et al.
Published: (2026)
by: Krystel Angela A. Olano, et al.
Published: (2026)
Similar Items
-
Amoxicillin‐Triggered Flare of Generalized Pustular Psoriasis in a Patient With Homozygous IL36RN Pathogenic Variant Treated With Spesolimab and Cyclosporin A
by: Koki Morita, et al.
Published: (2025) -
Radiation Recall Mucositis After Administration of Tegafur‐Gimeracil‐Oteracil Potassium ( TS ‐1)
by: Naoya Saito, et al.
Published: (2026) -
Spontaneous Resolution of Cutaneous Siderosis Caused by Extravasation of Intravenous Ferric Derisomaltose: Two Case Reports
by: Chihiro Sagara, et al.
Published: (2026) -
The Efficacy and Safety of Non‐Biologic and Biologic Treatments in Palmoplantar Pustular Psoriasis and Palmoplantar Pustulosis: A Systematic Review and Network Meta‐Analysis
by: Khalid M. Alshareef, et al.
Published: (2025) -
Paediatric Psoriasis and the Topical Treatment Guidance Gap in Australia
by: James Gaston, et al.
Published: (2026)